- Staat
- CA
- Alter
- 6,0
- Geschlecht
- M
- Eingang
- 04.10.2021
- Impfdatum
- 28.09.2021
- Beginn
- 29.09.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Fatigue
Increased tendency to bruise
Pyrexia
Rash macular
Seizure
Skin lesion
Symptomtext
Mother called 2 to 3 days after the vaccine indicating that patient had had fever of 103 Fahrenheit in addition to lacy rash with macules throughout upper and lower extremities. Mother also reported a seizure activity at home. Patient was not brought into the clinic nor were they brought into urgent care or emergency room. PCP was told days after the event. Patient doing well at home though continues to be fatigued with new lesions on upper and lower extremities per parent. Patient also having these macules around eyes however no conjunctivitis per parent. Patient is approximately almost 1 week out with these ongoing lesions and fatigue. Mother reports also easy bruising. Patient being treated conservatively at home use of Tylenol only for fevers. Mother has refused to take the patient to urgent care or to bring to the clinic for evaluation. We will continue to follow-up with patient in the next week.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- None
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 02.03.2021
- Impfdatum
- 02.03.2021
- Beginn
- 02.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Anaphylactic reaction
Cough
Dyspnoea
Throat tightness
Urticaria
Symptomtext
Patient had anaphylatic reaction consisting of tightness to throat, urticarial rash, SOB, cough
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anaphylactic reaction
- Hospital-Tage
- -
- Labordaten
- No tests performed. Received epi, steriods, antihistamine in emergency department
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- asthma laryngomalacia
- Andere Medikamente
- -
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 30.11.2021
- Impfdatum
- 18.05.2021
- Beginn
- 18.05.2021
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Adverse reaction
Gait disturbance
Imaging procedure
Injected limb mobility decreased
Injection site pain
Pain
Pain in extremity
Pyrexia
Symptomtext
MOTHER COMPLAINED OF PATIENT UNABLE TO BEND HIS LEFT LEG. THE PAIN IS PRESENT IN THE LEFT LEG ACHING, THE SYMPTOMS ARE AGGRAVATED BY MOVEMENT. HE HAS HAD LOW GRADE FEVER 100.0F PAIN AROUND THE INJECTION SITE, LIMPING NOTICED BY MOTHER, ON PHYSICAL EXAM NOTED INJECTION SITE 3 INCHES ABOVE THE SUPERIOR ASPECT OF PATELLA. JOINT IS NOT HOT PATIENT REFUSES PASSIVE RANGE OF MOTION OF KNEE. WHEN ASKED TO SQUAT PATIENT WILL FLEX KNEE TO 120 DEGREES. PATIENT DEMONSTRATES LIMP ON PHYSICAL EXAM. NO ERYTHEMA OR EDEMA NOTED AT INJECTION SITE. ADVERSE VACCINE REACTION VERSUS INFLAMMATION SECONDARY TO SUBOPTIMAL INJECTION PLACEMENT.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injected limb mobility decreased
- Hospital-Tage
- -
- Labordaten
- IMAGING COMPLETED OF LEFT KNEE TODAY DOES NOT REVEAL IMFLAMMATION SECONDARY TO SUBOPTIMAL INJECTION PLACEMENT. OVERLYING SKIN IS FLESH TONED. PEDAL PULSES +3 BILATERALLY. IMAGING COMPLETED TODAY DOES NOT REVEAL EFFUSION OR ANY ABNORMAL FINDINGS
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- BETAMEHASONE VALERATE 0.1% CREAM APPLY SMALL AMOUNT TO ADHESION TWICE DAILY X 4-6 WEEKS
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 6,0
- Geschlecht
- M
- Eingang
- 05.10.2023
- Impfdatum
- 19.06.2021
- Beginn
- 05.10.2023
- Tage bis Beginn
- 838,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pruritus
Pyrexia
Rash
Symptomtext
PATIENT CAME IN ON 10/05/2023, FEVER AND RASH OVER THE BODY ITCHING
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 26.03.2022
- Impfdatum
- 22.03.2022
- Beginn
- 22.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Immunisation reaction
Injection site swelling
Pain
Pyrexia
Symptomtext
Approximately 8-12 hrs after vaccine administration parents observed nickel-size swelling at injection site. Over the next 48 hrs, parents report that swelling gradually increased to the size of a softball and included localized redness and pain. Fever (Tmax 101) began 48 hrs after administration. Parents report redness, swelling, and pain were treated with ibuprofen, Benadryl, and ice at home. Due to ongoing redness, swelling, pain, and fever, parents were seen in our office approx 72 hrs after administration and diagnosed with localized vaccine reaction. Treatment recommendation included tylenol/ibuprofen, rest, and ice. Parents advised to follow-up with our office if symptoms worsened or did not improve. Awaiting confirmation of complete resolution of symptoms from family.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site swelling
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- -
- Andere Medikamente
- None
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 20.09.2021
- Impfdatum
- 30.08.2021
- Beginn
- 03.09.2021
- Tage bis Beginn
- 4,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Erythema
Pain
Swelling
Symptomtext
4 days after vaccination he developed a small red swollen area size of a quarter, by day 6-7 it was dark red raised, painful and the size of a softball.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- None
- Andere Medikamente
- n/a
- Allergien
- Amoxicillin
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 05.09.2021
- Impfdatum
- 27.08.2021
- Beginn
- 28.08.2021
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site swelling
Symptomtext
Redness and swelling of bilateral upper anterolateral thighs extending to knees. Treatment: intermittent cold compresses, Benadryl cream, Tylenol/Ibuprofen, improved redness/swelling.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- Cefdinir
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 05.09.2021
- Impfdatum
- 19.08.2021
- Beginn
- 20.08.2021
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Erythema
Pruritus
Skin warm
Swelling
Symptomtext
Per office note: 08/20/2021: FNP-BC Received picture Rt upper thigh itching and it is hot to the touch. Instructed mother to apply cold compress, use Benadryl cream on it, and if no improvement to call the office. on 08/21/21 mother sent a picture that pts leg was getting worse with redness and swelling. Instructed mother to give Tylenol and/or Ibuprofen for the discomfort and Benadryl PO, Mother states she ended up taking pt to the ER to get it checked out and they gave her a shot of steroids and symptoms improved.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- 07/26/2021 impetigo
- Vorgeschichte
- none
- Andere Medikamente
- -
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 22.07.2021
- Impfdatum
- 20.07.2021
- Beginn
- 21.07.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cellulitis
Hypersensitivity
Pyrexia
Rash erythematous
Rash vesicular
Symptomtext
Moderate cellulitis and fever within 24 hours with an erythematous, edematous and vesicular rash on left thigh. Start on oral antibiotics (Clindamycin) and topical antibiotics (Mupirocin). Advised to also continue Benadryl for the allergic reaction and Hydrocortisone cream if he develops itching around the injection sites.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Obesity, Developmental Delays
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- VI
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 11.06.2021
- Impfdatum
- 08.06.2021
- Beginn
- 08.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site rash
Injection site swelling
Laboratory test
Urticaria
Symptomtext
Mom stated child developed rash and swelling to injection sites after receving vaccines on June 8, 2021. Soon after hives spread about body. Mom admits child has "bad" allergies. Has Epi pen. . Mom administered Benadryl & tylenol every four hours for 2 days. She indicated that child normally takes benaryl for allergies. 6/11/21 seen by allergist. Labs ordered. Hx. Ecema since age 2 months of age. Has been on steriod meds 3 years for severe ezema. Denied swelilng to face or difficulty breathing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site rash
- Hospital-Tage
- -
- Labordaten
- Labs ordered.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Severe Ecema
- Andere Medikamente
- Benadryl
- Allergien
- Nuts, Gluten, Milk
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 08.06.2021
- Impfdatum
- 27.05.2021
- Beginn
- 29.05.2021
- Tage bis Beginn
- 2,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Induration
Mass
Pruritus
Symptomtext
Mom stated it is a really hard lump, size is about a inch, minimal pinkish color, very itchy but, stated that itchiness had went away just the hard lump is still there, no increase in size, and minimal warmth.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- No
- Aktuelle Erkrankungen
- -Foreign Body, left palm
- Vorgeschichte
- Asthma
- Andere Medikamente
- antibiotic
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 04.06.2021
- Impfdatum
- 03.06.2021
- Beginn
- 04.06.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash
Symptomtext
Localized rash on site started day after immunization. No treatment needed other than ibuprofen for comfort.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- Call placed to PCP
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- GERD (gastroesophageal reflux disease) Murmur Septicemia of newborn Ear malformation Cough Muscle twitching BMI (body mass index), pediatric, 95-99% for age Restless leg syndrome Atopic eczema Enlarged tonsils Bilateral otitis media Sleep disturbance Sleep talking Constipation Picky eater Generalized abdominal pain Behavior concern Insect bite of left forearm Rash in pediatric patient Photophobia of both eyes Poor articulation Speech delay
- Andere Medikamente
- Miralax as needed
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 02.06.2021
- Impfdatum
- 01.06.2021
- Beginn
- 02.06.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Injection site erythema
Injection site swelling
Symptomtext
4 inches x 3.5 inches x 0.8 inch high swelling of thigh with surrounding erythema on vaccine site
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 27.05.2021
- Impfdatum
- 19.05.2021
- Beginn
- 20.05.2021
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Erythema
Local reaction
Pain of skin
Symptomtext
Local skin reaction, redness, no swelling, no itching, minimal pain
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain of skin
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 21.05.2021
- Impfdatum
- 19.05.2021
- Beginn
- 21.05.2021
- Tage bis Beginn
- 2,0
- Dosis
- 4
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Erythema
Pain
Symptomtext
Redness spread upper thigh, patient states to have had pain.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 20.04.2021
- Impfdatum
- 20.04.2021
- Beginn
- 20.04.2021
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site indentation
Injection site reaction
Injection site swelling
Vaccination complication
Symptomtext
patient's right thigh has some mild erythema and swelling less than a centimeter diameter around the central injection site, and to the medial aspect there is an erythematous outline of the Band-Aid, then lateral to the central injection site there is a larger area of erythema and induration also where the Bandaid was but more extensively erythematous with wheal and flare reaction, including the injection site the involved area measures 6-1/2 cm in width horizontally by 3-1/2 cm in length vertically, the plaque was outlined with a skin marking pen. There is no confluence to the erythema and there is no significant warmth to touch. Provider believes that she has had a mild reaction to the vaccine, however it does not appear to be a secondary cellulitis. It may be a minor allergic versus localized reaction. Unaware of outcome, was just evaluated. Given topical hydrocortisone to use to area as needed.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 01.04.2021
- Impfdatum
- 24.03.2021
- Beginn
- 30.03.2021
- Tage bis Beginn
- 6,0
- Dosis
- 4
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site rash
Rash
Symptomtext
RASH TO LEFT UPPER ARM, RASH TO RIGHT THIGH THAT WRAPS AROUND TO BACK
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site rash
- Hospital-Tage
- -
- Labordaten
- CBC
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 6,0
- Geschlecht
- M
- Eingang
- 29.03.2021
- Impfdatum
- 26.03.2021
- Beginn
- 27.03.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site warmth
Symptomtext
Mother called to report increased redness and warmth at injection site no vesicles on 3/27. We will treat with Keflex and apply cool compress to affected area using cool wet as patient can tolerate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Tracheostomy, Vent dependence, Dev. Delay, GJ Dependence
- Andere Medikamente
- Tyelnol
- Allergien
- Amoxicillin, Benadryl, Rocephin, Sulfa, Vancomycin, Zonegran
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 26.03.2021
- Impfdatum
- 12.03.2021
- Beginn
- 17.03.2021
- Tage bis Beginn
- 5,0
- Dosis
- UNK
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Erythema
Swelling
Urticaria
Symptomtext
SWELLING, REDNESS, HIVES
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 25.03.2021
- Impfdatum
- 22.03.2021
- Beginn
- 23.03.2021
- Tage bis Beginn
- 1,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Pain
Skin warm
Urticaria
Symptomtext
RED AREA TO LEFT DELTOID WITH WELPS AND WARM TO TOUCH. ADVISED BY PROVIDER TO TAKE TYLENOL AND USE COLD PACKS FOR PAIN. GHOSH WANTS TO ALSO NOTE HERE, ALTHOUGH IT'S NOTED IN #17 THAT THE KINRIX (DTaP + IPV) WAS GIVEN IN LEFT ARM, INTRAMUSCULARLY.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 24.03.2021
- Impfdatum
- 22.03.2021
- Beginn
- 23.03.2021
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site pain
Injection site swelling
Injection site warmth
Symptomtext
Warm, red skin at injection site (right arm) from subcutaneous MMRV vaccine. It is swollen. Mother of the patient noticed it the next day at bath time since the site was covered with the bandaid. Mom reported that the patient complained of pain and warmth. Treatment: patient given Ibuprofen 12.5ml in office 3/24/21.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 10.03.2021
- Impfdatum
- 08.03.2021
- Beginn
- 09.03.2021
- Tage bis Beginn
- 1,0
- Dosis
- 5
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site erythema
Injection site pain
Injection site swelling
Injection site warmth
Pain in extremity
Symptomtext
Mom states pt woke up on 3/9 complaining of pain in left leg. Mom noted swelling, redness and warmth to touch on left anterior thigh. Mom called office and spoke with RN. RN advised to mark reddened area, apply cool compress and give Motrin. Mom had given Motrin and taken pt to daycare. Advised if worsening symptoms, have pt seen. Mom presented to office with pt the afternoon of 3/9. Pt complained of pain in left leg. Left thigh was notably larger in girth than the right thigh. There was dispersed light redness noted on anterior of left thigh with warmth to the touch. No fever noted. Pt was assessed by Dr. Pt was seen walking around office without issue. Called mom om 3/10/2021. Mom says the thigh continues to be a little swollen, but less than the day before. No other symptoms. Pt is walking and playing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- 02/17/2021 Pharyngitis
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- NKA
- Vorherige Impfungen
- Pedvax - 7/21/2017 - fever of 102 after vaccine
- Staat
- WV
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 08.02.2021
- Impfdatum
- 03.02.2021
- Beginn
- 03.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site swelling
Injection site warmth
Symptomtext
Patient developed redness to injection site same day of injection. Patient reported to our walk in clinic 2 days after injection for redness, warm, soft, non tender at injection site. Patient prescribed prednisolone and benadryl 2.5ml every 6 hours prn. Advised to report to clinic for a recheck and also advised to go to ER with any emergent concerns.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- No medications
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 29.01.2021
- Impfdatum
- 26.01.2021
- Beginn
- 27.01.2021
- Tage bis Beginn
- 1,0
- Dosis
- N/A
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cellulitis
Coeliac disease
Erythema
Induration
Injection site swelling
Pruritus
Skin warm
Swelling
Symptomtext
Within 24hrs erythema and swelling at site of injection. Suspected to be around site of Kinrix injection. By 48h post vaccine, tennis ball size area of redness, itching and swelling. By 72hrs, erythema had spread to entire anterior thigh, was hard and warm to touch. No fevers. Mom did try giving motrin but did not improve symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site swelling
- Hospital-Tage
- -
- Labordaten
- No testing. Did prescribe Keflex for cellulitis.
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- asthma
- Andere Medikamente
- no
- Allergien
- no
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 13.01.2021
- Impfdatum
- 11.01.2021
- Beginn
- 13.01.2021
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site mass
Symptomtext
Redness around injection site and mom advised us that she feels a lump
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- no
- Andere Medikamente
- none
- Allergien
- nkda
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 26.11.2022
- Impfdatum
- 19.05.2022
- Beginn
- 19.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
Patient received Kinrix instead of Pediarix/Kinrix was the 3rd Dtap and IPV dose for patient; 12 month old patient received Kinrix; This case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 12-month-old female patient who received DTPa-IPV (Kinrix) (batch number YZ97N, expiry date 26th August 2022) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. Previously administered products included pediarix (1st dose received on 11th August 2022), pediarix (2nd dose received on 10th November 2022) and hepatitis B vaccine (received 3 hapatitis B vaccine on an unknown date). On 19th May 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 19th May 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered and inappropriate age at vaccine administration. On an unknown date, the outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 16-NOV-2022 Reporter's Comments: The health care professional (HCP) called to report a medical error, patient was supposed to receive Pediarix but received Kinrix. On 19th May 2022, a 12 months female baby received a Kinrix vaccine. This was the third Dtap dose on patient's schedule. It was the patient's 3rd dose of IPV too. The reporter consented to follow up. Additional Supportive Information: The patient was administered with kinrix instead of Pediarix, which led to Wrong vaccine administered and inappropriate age at vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 8,0
- Geschlecht
- M
- Eingang
- 12.10.2022
- Impfdatum
- 30.09.2022
- Beginn
- 30.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Expired Kinrix administered; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 8-year-old male patient who received DTPa-IPV (Kinrix) (batch number YZ97N, expiry date 26th August 2022) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 30th September 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 30th September 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 03-OCT-2022 Reporter's Comment: The registered nurse reported that a dose of Kinrix given to the patient and it was already expired. The reporter did not consent to follow up. The Vaccine Administration Facility was the same as primary reporter. Additional Supportive Information: The use of Kinrix dose, which was already expired on 26th August 2022, which led to expired vaccine used.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- U
- Eingang
- 17.09.2022
- Impfdatum
- 06.09.2022
- Beginn
- 06.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
patient was administrated with an expired dose of Kinirx on September 26 2022. The vaccine expired on August 26 2022; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a patient who received DTPa-IPV (Kinrix) (batch number yz97n, expiry date 26th August 2022) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 6th September 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 6th September 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 06-SEP-2022 Reporters comment: The medical assistant reported that the patient was administrated with an expired dose of Kinirx on 26th September 2022. The vaccine expired on 26th August 2022. No adverse event was reported The reporter consent to follow-up. No patient's identifiers were provided Additional Supportive information: The patient was administrated with an expired dose of Kinirx on 26th September 2022 which was already expired in 26th August 2022. which led to Expired vaccine used.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 17.09.2022
- Impfdatum
- 30.08.2022
- Beginn
- 30.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Expired kinrix administered; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 4-year-old female patient who received DTPa-IPV (Kinrix) (batch number YZ97N, expiry date 26th August 2022) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 30th August 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 30th August 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 2-Sept-2022 Reporter's comment: The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow-up. Additional supportive information: The patient receive an expired dose of Kinrix, which led to expired vaccine used.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 10.09.2022
- Impfdatum
- 31.08.2022
- Beginn
- 31.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
she gave an expired Kinrix vaccine to a patient; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 4-year-old male patient who received DTPa-IPV (Kinrix) (batch number Yz97n, expiry date 26th August 2022) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 31st August 2022, the patient received the 1st dose of Kinrix (intramuscular) .5 ml and Kinrix Pre-Filled Syringe Device. On 31st August 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 31-AUG-2022 The nurse stated that she gave an expired Kinrix vaccine to a patient. She did not report that the patient was experiencing any side effects. The reporter did not consent to follow-up. Additional supportive information: The patient had received an expired dose of Kinrix, which led to expired vaccine used.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 10.09.2022
- Impfdatum
- 29.08.2022
- Beginn
- 29.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Expired Kinrix admiistered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 4-year-old male patient who received DTPa-IPV (Kinrix) (batch number YZ97N, expiry date 26th August 2022) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 29th August 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 29th August 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 31-AUG-2022 Reporter's Comment: The lead medical assistant stated that an expired dose of Kinrix was administered to a patient on Monday. The reporter consented to follow up via postal. Additional Supportive Information: The patient received an expired dose of Kinrix, which led to expired vaccine used.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 05.09.2022
- Impfdatum
- 30.08.2022
- Beginn
- 30.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Expired Kinrix administered; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 5-year-old male patient who received DTPa-IPV (Kinrix) (batch number YZ97N, expiry date 26th August 2022) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 30th August 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 30th August 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 30-AUG-2022 Reporter's Comment: The reporter was a nurse. The reporter reported that the patient received Kinrix vaccine after expiration date. The reporter consented to follow up. Additional supportive information: The patient received a Kinrix which was already expired, which led to expired vaccine used.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 03.09.2022
- Impfdatum
- 27.08.2022
- Beginn
- 27.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
received expired dose; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 4-year-old male patient who received DTPa-IPV (Kinrix) (batch number YZ97N, expiry date 26th August 2022) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 27th August 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 27th August 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 29-Aug-2022 Reporter's comment: The reporter consented to follow-up via email. Additional supportive information: The patient received an expired dose of Kinrix, which led to expired vaccine used.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 6,0
- Geschlecht
- M
- Eingang
- 02.09.2022
- Impfdatum
- 29.08.2022
- Beginn
- 29.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Expired Kinrix administered; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 6-year-old male patient who received DTPa-IPV (Kinrix) (batch number YZ97N, expiry date 26th August 2022) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 29th August 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 29th August 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 29-AUG-2022 Reporter's Comment: The nurse reported that a patient received an expired dose of Kinrix on 29Aug2022. The vaccine expired on 26Aug2022. No symptoms reported. The reporter gave consent to follow up. Additional Supportive Information: The patient received expire dose, which led to expired vaccine used.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 02.09.2022
- Impfdatum
- 29.08.2022
- Beginn
- 29.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Expired Kinrix administered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 4-year-old male patient who received DTPa-IPV (Kinrix) (batch number YZ97N, expiry date 26th August 2022) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 29th August 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 29th August 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 29-AUG-2022 Reporter's Comment: The reporter stated that the Kinrix was administered on 29AUG2022 and expired on 26AUG2022. No reactions reported. The reporter gave consent to follow up. Additional Supportive Information: The patient received expire Kinrix dose, which led to expired vaccine used.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 31.08.2022
- Impfdatum
- 31.08.2022
- Beginn
- 31.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
Patient given Kinrix vaccine which expired on 8/26/22. No adverse events observed at time of administrations.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Nothing.
- Vorgeschichte
- Nothing noted in EMR.
- Andere Medikamente
- Nothing.
- Allergien
- No allergies.
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 30.08.2022
- Impfdatum
- 30.08.2022
- Beginn
- 30.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Kinrix vaccine given had expiration date of 8/26/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Hirschsprungs disease
- Andere Medikamente
- None known
- Allergien
- None known
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 1,3
- Geschlecht
- F
- Eingang
- 30.08.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
6 month old was administrated with Kinrix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 15-month-old female patient who received DTPa-IPV (Kinrix) (batch number yz97n, expiry date unknown) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. In November 2021, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. In November 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 22-AUG-2022 Reporter's comments: Nurse reported that a 6-month female patient was administrated with Kinrix. No adverse event was reported. The vaccination occurred on another facility. The Healthcare Professional (HCP) wanted to be contacted by phone. The expiration date was not provided. The reporter consented to follow-up. Additional supportive information: The patient was administered Kinrix while she was 6-month old which had led to inappropriate age at vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 29.08.2022
- Impfdatum
- 29.08.2022
- Beginn
- 29.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Unevaluable event
Symptomtext
Per Dr. patient will need an appointment in 2 days to see if there is an adverse reaction.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- Autism
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- N.K.D.A.
- Vorherige Impfungen
- -
- Staat
- DE
- Alter
- 0,8
- Geschlecht
- F
- Eingang
- 15.06.2022
- Impfdatum
- 09.05.2022
- Beginn
- 09.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
Administered to a 9 month old.; Patient did not need the Hep B but needed the IPV component.; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 9-month-old female patient who received DTPa-IPV (Kinrix) (batch number YZ97N, expiry date 26th August 2022) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 9th May 2022, the patient received the 4th dose of Kinrix and Kinrix Pre-Filled Syringe Device. On 9th May 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 8-JUN-2022 Reporter's Comment: This case was reported by the certified medical assistant (CMA). Kinrix was administered to a 9 month old patient. She stated that all they had in stock was the DTap-IPV-Hep B and the Dtap, but the patient did not need the Hep B but needed the IPV component. Additional Suportive Information: The patient received Kinrix at 9 months age and did not need Hep B component, which led to inappropriate age at vaccine administration and wrong vaccine administered. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 2,0
- Geschlecht
- F
- Eingang
- 12.05.2022
- Impfdatum
- 09.05.2022
- Beginn
- 09.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
Administration of Kinrix instead of Infanrix; Administration of Kinrix to a 24 month old patient; This case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 24-month-old female patient who received DTPa-IPV (Kinrix) (batch number YZ97N, expiry date 26th August 2022) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 9th May 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 9th May 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered and inappropriate age at vaccine administration. On an unknown date, the outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 09-May-2022 Reporter's Comments: The Healthcare professional called to report the administration of Kinrix to a child but had intended to give Infanrix. AE filed. Provided Medical information phone number for reporter's reference and a warm transfer to Medical information. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up. Additional Supportive Information: The patient received Kinrix vaccine instead of Infanrix, which led to wrong vaccine administered and inappropriate age at vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 2,0
- Geschlecht
- F
- Eingang
- 09.05.2022
- Impfdatum
- 09.05.2022
- Beginn
- 09.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
DTAP + IPV (Kinrix) given to patient instead of DTAP (Infanrix). No adverse s/s.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- ferrous sulfate, hydrocortisone cream, Zyrtec, hydroxyzine, tylenol
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 15.03.2022
- Impfdatum
- 07.03.2022
- Beginn
- 07.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Patient might have accidentally received Kinrix Lot H9Y52, expiration 1/31/22. There is currently no way to verify. Contacted manufacturer, GSK, who stated "results from in-house analytical potency testing have shown that Kinrix remains within the approved specifications for up to 30 days following the expiration date of the vaccine if stored under appropriate temperature and storage conditions." Based on this, the patient would need to be re-vaccinated as the vaccine was administered after 30 days of vaccine expiration. Patient's parent was contacted, re-vaccination appointment set up for 3/16/22. Parent was encouraged to reach out to our facility with any questions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Unknown.
- Vorgeschichte
- Unknown.
- Andere Medikamente
- Unknown.
- Allergien
- Unknown.
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 15.03.2022
- Impfdatum
- 22.02.2022
- Beginn
- 22.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Patient might have accidentally received Kinrix Lot H9Y52, expiration 1/31/22. There is currently no way to verify. Contacted manufacturer, GSK, who stated "results from in-house analytical potency testing have shown that Kinrix remains within the approved specifications for up to 30 days following the expiration date of the vaccine if stored under appropriate temperature and storage conditions." Based on this, the patient would not need to be re-vaccinated even if they did receive the expired vaccine, as it was administered within 30 days of vaccine expiration. No further action taken.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Unknown.
- Vorgeschichte
- Unknown.
- Andere Medikamente
- Unknown.
- Allergien
- Unknown.
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 2,0
- Geschlecht
- M
- Eingang
- 11.03.2022
- Impfdatum
- 06.01.2022
- Beginn
- 11.03.2022
- Tage bis Beginn
- 64,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
Kinrix was administered to a child L deltoid-Age 2yr 4 mo-DTaP and IPV should have been given in separate doses-Kinrix to be administered as booster dose @ 4 y.o and older-The dose is considered valid and does not require repeating-PHN has reviewed information and voices understanding
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- N/A
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 1,3
- Geschlecht
- F
- Eingang
- 09.03.2022
- Impfdatum
- 08.02.2022
- Beginn
- 08.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- SYR / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Wrong product administered
Symptomtext
PATIENT WAS GIVEN KINRIX LOT NO YZ97N ON 02/08/2022 IN ERROR, PATIENT SHOULD HAVE RECEIVED INFANRIX LOT NO 49TM3
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- UNKNOWN
- Vorgeschichte
- UNKNOWN
- Andere Medikamente
- UNKNOWN
- Allergien
- UNKNOWN
- Vorherige Impfungen
- -
- Staat
- MT
- Alter
- 0,3
- Geschlecht
- F
- Eingang
- 03.02.2022
- Impfdatum
- 03.02.2022
- Beginn
- 03.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Wrong product administered
Symptomtext
Kinrix administered instead of separate DTap & IPV injections. No reaction. Verified no change in schedule with state. MD aware
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none known
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 0,8
- Geschlecht
- F
- Eingang
- 11.01.2022
- Impfdatum
- 22.12.2020
- Beginn
- 22.12.2020
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
9 month old receiving Kinrix; receiving Kinrix instead of Pediarix; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 9-month-old female patient who received DTPa-IPV (Kinrix) (batch number YZ97N, expiry date 26th August 2022) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 22nd December 2020, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 22nd December 2020, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The reporter was an Health care professionals. The patient had received a shot of Kinrix instead of Pediarix at 9 months of age, which led to inappropriate age at vaccine administration and wrong vaccine administered. The reporter stated that they realized this mistake on Thursday before reporting date. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 0,3
- Geschlecht
- F
- Eingang
- 28.12.2021
- Impfdatum
- 28.10.2020
- Beginn
- 28.10.2020
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
4 months old patient receiving KINRIX instead of Pediarix; 4 months old patient receiving KINRIX; This case was reported by a pharmacist via call center representative and described the occurrence of wrong vaccine administered in a 4-month-old female patient who received DTPa-IPV (Kinrix) (batch number YZ97N, expiry date 26th August 2022) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 28th October 2020, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 28th October 2020, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered and inappropriate age at vaccine administration. On an unknown date, the outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The patient received dose of Kinrix at the age of 4 months instead of Pediarix, which led to wrong vaccine administered and inappropriate age at vaccine administration. The reporter consented to follow up. This case was 1 of 6 linked cases, reported by same reporter for different patient.; Sender's Comments: US-GLAXOSMITHKLINE-US2021159292:Same reporter US-GLAXOSMITHKLINE-US2021159295:Same reporter US-GLAXOSMITHKLINE-US2021254893:Same reporter US-GLAXOSMITHKLINE-US2021254941:Same reporter US-GLAXOSMITHKLINE-US2021260746:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 3,0
- Geschlecht
- M
- Eingang
- 28.12.2021
- Impfdatum
- 17.12.2021
- Beginn
- 17.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
received KINRIX instead of DTAP; 3YO patient (DOB: 4/23/2018) received KINRIX instead of DTAP; This case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 3-year-old male patient who received DTPa-IPV (Kinrix) (batch number YZ97N, expiry date 26th August 2022) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 17th December 2021, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 17th December 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered and inappropriate age at vaccine administration. On an unknown date, the outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The patient received dose of Kinrix at the age of 3 years old instead of DTAP, which led to wrong vaccine administered and inappropriate age at vaccine administration. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 0,3
- Geschlecht
- F
- Eingang
- 21.12.2021
- Impfdatum
- 28.10.2020
- Beginn
- 28.10.2020
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
Patient received Kinrix at 4 months; Kinrix given instead of Pediarix; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a 4-month-old female patient who received DTPa-IPV (Kinrix) (batch number YZ97N, expiry date 26th August 2022) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. Concomitant products included DTPa-HBV-IPV (Pediarix). On 28th October 2020, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 28th October 2020, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device and not applicable after receiving Pediarix, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were reported as follows: The patient received 1st dose of pediarix on an unknown date. The reporter stated that, the nurse documented administering a dose of Pediarix to the patient, however search of lot number YZ97N revealed that the dose was actually Kinrix. The patient was 4 months old and received Kinrix instead of Pediarix, which led to inappropriate age at vaccine administration and wrong vaccine administered. The reporter consented to follow up. This is one of 4 cases, reported by the same reporter.; Reporter's Comments: Pharmacist reports a nurse documented administering a dose of Pediarix to a patient , however search of lot number YZ97N revealed that the dose was actually Kinrix. The dose was administered on 28Oct2020 (child was 16 months of age). This was supposed to have been the second dose of the Pediarix series. The expiration date of the Kinrix dose administered was 26Aug2022. ~~~~~~~Consented to follow up.Call Notes:HCP gave permission for follow-up; Sender's Comments: US-GLAXOSMITHKLINE-US2021254893:Same reporter US-GLAXOSMITHKLINE-US2021254961:Same reporter US-GLAXOSMITHKLINE-US2021159295:Same reporter US-GLAXOSMITHKLINE-US2021159292:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Pediarix
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 10.12.2021
- Impfdatum
- 14.10.2021
- Beginn
- 14.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Wrong product administered
Symptomtext
Administered Kinrix instead of Tdap
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 3,0
- Geschlecht
- F
- Eingang
- 27.11.2021
- Impfdatum
- 22.11.2021
- Beginn
- 22.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Product administered to patient of inappropriate age
Symptomtext
Kinrix was administered to a 3 year old; Was the 3rd dose in series for Dtap; received kinrix in Lt. Vastus Lateralis; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 3-year-old female patient who received DTPa-IPV (Kinrix) (batch number YZ97N, expiry date 26th August 2022) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 22nd November 2021, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 22nd November 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration, inappropriate schedule of vaccine administered and vaccine administered at inappropriate site. On an unknown date, the outcome of the inappropriate age at vaccine administration, inappropriate schedule of vaccine administered and vaccine administered at inappropriate site were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The patient received Kinrix in Lt. Vastus Lateralis, which led to vaccine administered at inappropriate site. The Kinrix was administered to a 3 year old and this was their 3rd dose in series for Dtap, which led to inappropriate age at vaccine administration and inappropriate schedule of vaccine administered. No reactions reported. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 04.11.2021
- Impfdatum
- 22.09.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 5
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
No adverse event
Symptomtext
Patient was administered a vaccine that had expired 3 days ago. No reaction. MMR Vaccine will be repeated at next appointment in March 2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- Cetirizine, Loratadine
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 26.10.2021
- Impfdatum
- 26.10.2021
- Beginn
- 26.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Interchange of vaccine products
Symptomtext
PATIENT WAS GIVEN A DOSE OF DTAP VACCINE AND KINRIX AT THE SAME VISIT, ONE IN EACH ARM. NO IMMEDIATE REACTION WAS SEEN BUT FOLLOW UP WILL BE DONE TO ASSESS THE WELL BEING OF THE CLIENT POST VACCINATION.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 0,3
- Geschlecht
- M
- Eingang
- 17.09.2021
- Impfdatum
- 08.09.2021
- Beginn
- 08.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
4 month old was given Kinrix; This case was reported by a consumer via call center representative and described the occurrence of inappropriate age at vaccine administration in a 3-month-old male patient who received DTPa-IPV (Kinrix) (batch number YZ97N, expiry date 31st August 2022) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 8th September 2021, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 8th September 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The case was reported by patient's mother. The patient's mother stated that 4 month old son was given a shot of Kinrix which was indicated for 4 to 6 year old children, which led to inappropriate age at vaccine administration. No health care professional information was provided. The reporter did not consent to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Kinrix Pre-Filled Syringe Device
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 1,3
- Geschlecht
- F
- Eingang
- 21.08.2021
- Impfdatum
- 01.07.2021
- Beginn
- 01.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Administration / to a / 1 year(s) 4 month(s) 20 day(s) old; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 1-year-old female patient who received DTPa-IPV (Kinrix) (batch number YZ97N, expiry date 26th August 2022) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 1st July 2021, the patient received Kinrix (intramuscular) and Kinrix Pre-Filled Syringe Device. On 1st July 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided are as follows: The health care professional reported that, the administration of Kinrix done to the patient who was 1 year 4 months and 20 days old at the time, which led inappropriate age at vaccine administration. The reporter provided phone number for HCP reference and a warm transferred. The reporter consented to follow-up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Kinrix Pre-Filled Syringe Device
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 2,0
- Geschlecht
- F
- Eingang
- 20.08.2021
- Impfdatum
- 19.08.2021
- Beginn
- 19.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
Patient was given wrong vaccine. Wrong vaccine given was Kinrix. Mother notified of this. No adverse side effect noted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 0,2
- Geschlecht
- F
- Eingang
- 12.08.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
2 month old patient received a dose of Kinrix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 2-month-old female patient who received DTPa-IPV (Kinrix) (batch number YZ97N, expiry date 26th August 2022) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On an unknown date, the patient received the 1st dose of Kinrix and Kinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The reporter reported that the 2 months old patient inadvertently received a dose of Kinrix which led to inappropriate age at vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 11.08.2021
- Impfdatum
- 10.08.2021
- Beginn
- 10.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administration error
Symptomtext
ADMINISTRATION ERROR : Previously 11/30/2020 received DTaP +IPV, Re-administered 08/10/2021. No noted symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administration error
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 10.08.2021
- Impfdatum
- 10.08.2021
- Beginn
- 10.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product preparation issue
Symptomtext
MMRV was reconstituted with Pedvax HIB instead of sterile dilute
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product preparation issue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- na
- Vorgeschichte
- na
- Andere Medikamente
- na
- Allergien
- na
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 1,8
- Geschlecht
- F
- Eingang
- 27.07.2021
- Impfdatum
- 27.07.2021
- Beginn
- 27.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
Kinrix given instead of Infanrix
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- no
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 3,0
- Geschlecht
- F
- Eingang
- 26.07.2021
- Impfdatum
- 21.07.2021
- Beginn
- 21.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cold sweat
Eye injury
Fall
Feeling abnormal
Feeling cold
Ocular hyperaemia
Periorbital swelling
Symptomtext
Approx. five minutes after series of three vaccinations, child was sitting in a chair and appeared to be bending over to pick up an item on the floor, which she had just dropped. She slumped to the right and and fell into the table which she was sitting by and landed on the floor, hitting the right side of her on the way out of the chair on the table. MOC and I were standing right beside her and she never fully lost consciousness. She was able to respond and talk right away upon bending down to her. She was cool, clammy and dazed with her gaze and slow to speak. She did rouse and speak normally within 2-3 minutes. No apparent injuries noted, other than the mark by the right eye, where she hit it. Positioned child flat on back with feet elevated. Cold washcloth applied to back of neck and forehead. Kept child approx 30 minutes after incidence to make sure she was acting and responding appropriately for a normal 3 year old. Did discuss s/s of concussion with MOC and appropriateness to seek medical attention. Encouraged if any new developing issues to see ASAP. Called MOC on 7-26-2021 to provide follow up. MOC reports that child seemed to not have any lasting effects from that day. States that she did have some redness and puffiness to Left eye that afternoon of incidence, but felt that it was related to holding the cat, which she believes that child may have an allergy to.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cold sweat
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- no known health conditions
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 2,0
- Geschlecht
- F
- Eingang
- 12.06.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
a 29 month old patient received a dose of Kinrix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 29-month-old female patient who received DTPa-IPV (Kinrix) (batch number YZ97N, expiry date 22nd August 2022) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On an unknown date, the patient received Kinrix (intramuscular) and Kinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: Nurse practitioner reported a 29 month old patient received a dose of Kinrix., which led to inappropriate age at vaccine administration. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 0,9
- Geschlecht
- F
- Eingang
- 08.06.2021
- Impfdatum
- 02.06.2021
- Beginn
- 02.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Product administered to patient of inappropriate age
Symptomtext
11 month old patient had been given Kinrix; Kinrix 3rd dose in the DTaP series and the 3rd dose in the polio series; This case was reported by a physician via call center representative and described the occurrence of inappropriate age at vaccine administration in a 11-month-old female patient who received DTPa-IPV (Kinrix) (batch number YZ97N, expiry date 26th August 2022) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. Previously administered products included HEPATITIS B VACCINE (received prior 3 doses of series on an unknown date) and DTPa-IPV (received prior 3 doses of series on an unknown date). On 2nd June 2021, the patient received the 3rd dose of Kinrix and Kinrix Pre-Filled Syringe Device. On 2nd June 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and inappropriate schedule of vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The patient received Kinrix at 11 months of age, which led to inappropriate age at vaccine administration. The patient received Kinrix to provide the 3rd dose in the DTaP series and the 3rd dose in the polio series, which led to inappropriate schedule of vaccine administered. The Pediarix was to be given but patient had completed 3 doses of Hepatitis B already. At the time of reporting, the dose was given and after realizing age recommendations on health care professional called for safety and composition information. Health care professional did not have all information at hand and provided limited data, initials not shared. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 0,4
- Geschlecht
- M
- Eingang
- 01.06.2021
- Impfdatum
- 26.04.2021
- Beginn
- 26.04.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
Patient who was seen in office on 4/26/21 with FNP for a Well Child Exam. Patient was due for immunizations at time of his appointment. At his appointment the patient was given the Kinrix vaccine. The patient is 5months old and this is a 4-6 year vaccine. Patient had no reactions when in office or when leaving office. Mother was notified of incident and states the patient is still doing well no reactions has taken place.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 20.05.2021
- Impfdatum
- 04.03.2021
- Beginn
- 04.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
kinrix given to a 19 month old; was due for 3rd dose of ipv and dtap / Kinrix was administered on 3/4/2021 as a 3rd dose in the series; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 1-year-old female patient who received DTPa-IPV (Kinrix) (batch number yz97n, expiry date 26th August 2022) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. Previously administered products included DTPa-IPV vaccine (Received 2nd dose on March 2020.). On 4th March 2021, the patient received the 3rd dose of Kinrix and Kinrix Pre-Filled Syringe Device. On 4th March 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and inappropriate schedule of vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follow: The patient received 3rd dose of Kinrix at 19 months of age which leads to inappropriate age at vaccination and inappropriate schedule of vaccine administered. Medical administrator called to inquire how should they continue with vaccination. Forget to ask for follow up, , however did collect contact information if necessary.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- M
- Eingang
- 27.04.2021
- Impfdatum
- 20.04.2021
- Beginn
- 20.04.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Inappropriate schedule of product administration
Symptomtext
received on feb 9th their 3rd dose of pediarix/ On 4/20/2021 received/ engerix; On 4/20/2021 received/ DOSE 1( 4TH DOSE OF DTAP AND POLIO) of kinrix.; On 4/20/2021 received/ DOSE 1( 4TH DOSE OF DTAP AND POLIO) of kinrix.; This case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 9-month-old male patient who received HBV (Engerix B) (batch number YL2L3, expiry date 14th December 2021) for prophylaxis. Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa-IPV (Kinrix) (batch number YZ97N, expiry date 26th August 2022) for prophylaxis and dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. Concomitant products included DTPa-HBV-IPV (Pediarix). On 20th April 2021, the patient received the 4th dose of Engerix B, Engerix B Pre-Filled Syringe Device, the 1st dose of Kinrix and Kinrix Pre-Filled Syringe Device. On 20th April 2021, unknown after receiving Engerix B and Engerix B Pre-Filled Syringe Device and not applicable after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced extra dose administered, inappropriate age at vaccine administration and inappropriate schedule of vaccine administered. On an unknown date, the outcome of the extra dose administered, inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The patient received 3rd dose of Pediarix on 9th February 2021. The patient received Engerix B, this becames an extra dose of Hepatitis B. The patient received Kinrix as a 4th dose of Dtap and IPV, which led to inappropriate age at vaccine administration and inappropriate schedule of vaccine administered. The reported batch number for Kinrix was YZNZN, which was updated to YZ97N as per sales datasheet. The reporter consented to follow-up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Pediarix
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 7,0
- Geschlecht
- M
- Eingang
- 23.03.2021
- Impfdatum
- 13.01.2021
- Beginn
- 13.01.2021
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Kinrix vaccine was administered to a 7 year old patient. Kinrix is licensed through the age of 6 years. Patient has not reported any adverse reactions or events after vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- None known
- Vorgeschichte
- None known
- Andere Medikamente
- None known
- Allergien
- None known
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 1,6
- Geschlecht
- M
- Eingang
- 10.02.2021
- Impfdatum
- 10.02.2021
- Beginn
- 10.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Wrong product administered
Symptomtext
child inadvertently given a kinrix when a prevnar (pneumococcal 13) and hib had been ordered. No adverse effects immediately noted. Family notified. Will wait one month then give prevnar and hib.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- nkda
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 03.02.2021
- Impfdatum
- 01.02.2021
- Beginn
- 02.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Contusion
Erythema
Symptomtext
Bruising with large area of surrounding redness
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Contusion
- Hospital-Tage
- -
- Labordaten
- F/U appt.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Multi-vitamin with fluoride
- Allergien
- None
- Vorherige Impfungen
- -